Evidence map›Paper›PMID 23817617›Full record

ArticleInfection and immunity2013

Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.

Rajarshi Bhadra, Dustin A Cobb, Imtiaz A Khan

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Effects ofFood and waterborne parasitology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and ChronicFrontiers in cellular and infection microbiology · 2020
    Article
  11. Article
  12. Review
  13. Toxoplasma: Immunity and Pathogenesis.Current clinical microbiology reports · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Recent advances in Toxoplasma gondii immunotherapeutics.The Korean journal of parasitology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rajarshi BhadraDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA.
Dustin A Cobb
Imtiaz A Khan
George Washington University · US

Funding

LONG TERM IMMUNITY AGAINST TOXOPLASMOSISR01AI033325 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI KHAN, IMTIAZ AHMED · 1998 to 2020
$6.2M
LONG TERM IMMUNITY AGAINST TOXOPLASMOSISR21AI033325 · NIAID · DARTMOUTH COLLEGE · PI KHAN, IMTIAZ AHMED · 1997 to 1997
–
TOXOPLASMA GONDII MEDIATED IMMUNOSUPPRESSIONR29AI033325 · NIAID · DARTMOUTH COLLEGE · PI KHAN, IMTIAZ AHMED · 1992 to 1996
–
NIAID NIH HHS AI-33325NIAID NIH HHS R01 AI033325
6 · The paper itself

Abstract

Functional exhaustion of CD8(+) T cells due to increased expression of inhibitory molecule PD-1 (Programmed Death-1) causes reactivation of latent disease during later phases of chronic toxoplasmosis. Onset of disease recrudescence results in decreased parasite cyst burden concomitant with parasites undergoing stage conversion from a primarily encysted, quiescent bradyzoite to a fast-replicating, highly motile tachyzoite. Thus, reduced cyst burden is one of the early hallmarks of disease recrudescence. This was further validated by depleting gamma interferon (IFN-γ), a cytokine known to control latent toxoplasmosis, in chronically infected prerecrudescent mice. Since CD8(+) T cells (an important source of IFN-γ) lose their functionality during the later phases of chronic toxoplasmosis, we next examined if adoptive transfer of functional CD8(+) T cells from acutely infected donors to the chronically infected prerecrudescent hosts could impede parasite de-encystation and rescue exhausted CD8(+) T cells. While the transfer of immune CD8(+) T cells temporarily restricted the breakdown of cysts, the exhausted endogenous CD8(+) T cell population was not rescued. Over time, the donor population got deleted, resulting in parasite de-encystation and host mortality. Considering that donor CD8(+) T cells fail to become long-lived, one of the cardinal features of memory CD8(+) T cells, it bears the implication that memory CD8 differentiation is impaired during chronic toxoplasmosis. Moreover, our data strongly suggest that while adoptive immunotherapy can prevent parasite de-encystation transiently, reduced antigen burden in the chronic phase by itself is insufficient for rescue of exhausted CD8(+) T cells. The conclusions of this study have profound ramifications in designing immunotherapeutics against chronic toxoplasmosis.

Indexed as

Adoptive TransferAnimalsCD8-Positive T-LymphocytesFemaleImmunotherapy, AdoptiveInterferon-gammaMiceMice, Inbred C57BLToxoplasmaToxoplasmosisInterferon-gamma

Identifiers

PMID23817617
PMCPMC3754203
OpenAlexW2130825184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.